If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:41100-52-1
Source:India
Qualifications:USDMF/-/-/-/-
Name | Memantine Hydrochloride |
---|---|
Chinese name | 盐酸美金刚 |
Cas Number | 41100-52-1 |
Source | India |
Qualifications | USDMF/-/-/-/- |
Memantine hydrochloride is a dementia treatment drug developed by German Merz company. It is a new, low-to-moderate affinity, voltage-dependent, non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. It can block NMDA receptors non-competitively, reduce the excessive excitement of NMDA receptors caused by glutamate, prevent cell apoptosis and improve memory. It is a new generation of drugs to improve cognitive function. Memantine is currently approved for the treatment of moderate to severe AD in Europe, and is used for the treatment of moderate to severe AD in the United States. Further research shows that memantine hydrochloride is also effective for patients with mild to moderate Alzheimer's disease.
Hot Tags: memantine hydrochloride api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Aprepitant Aprepitant API, Escitalopram Oxalate API, Salmeterol Xinafoate API, Dapoxetine API, Brinzolamide API, Lurasidone Hydrochloride API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China